Excision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin: A review of current literature
- 31 May 2009
- journal article
- review article
- Published by Elsevier in Lung Cancer
- Vol. 64 (2) , 131-139
- https://doi.org/10.1016/j.lungcan.2008.08.006
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- ERCC1 Genotype and Phenotype in Epithelial Ovarian Cancer Identify Patients Likely to Benefit From Paclitaxel Treatment in Addition to Platinum-Based TherapyJournal of Clinical Oncology, 2007
- Customizing Cisplatin Based on Quantitative Excision Repair Cross-Complementing 1 mRNA Expression: A Phase III Trial in Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2007
- Cisplatin- Versus Carboplatin-Based Chemotherapy in First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: An Individual Patient Data Meta-analysisJNCI Journal of the National Cancer Institute, 2007
- A Gynecologic Oncology Group Study of Platinum-DNA Adducts and Excision Repair Cross-Complementation Group 1 Expression in Optimal, Stage III Epithelial Ovarian Cancer Treated with Platinum-Taxane ChemotherapyCancer Research, 2007
- Pharmacogenetic Profiling in Patients With Advanced Colorectal Cancer Treated With First-Line FOLFOX-4 ChemotherapyJournal of Clinical Oncology, 2007
- Prognostic value of expression of ERCC1, thymidylate synthase, and glutathione S-transferase P1 for 5-fluorouracil/oxaliplatin chemotherapy in advanced gastric cancerAnnals of Oncology, 2007
- XRCC1 R399Q polymorphism is associated with response to platinum-based neoadjuvant chemotherapy in bulky cervical cancerGynecologic Oncology, 2006
- DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant ChemotherapyNew England Journal of Medicine, 2006
- A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancerBritish Journal of Cancer, 2004
- Expression of Genes of Potential Importance in the Response to Chemotherapy and DNA Repair in Patients with Ovarian CancerGynecologic Oncology, 1997